Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry in diagnosis of clinical Nocardia species

• Published in: Journal of laboratory medicine 2019-06, Vol.43 (3), p.157-162
• Main Authors: Hasçelik, Gülşen, Kostrzewa, Markus, Kaan Müştak, Hamit, Uner, Celalettin, Serdar Diker, Kadir
• Format: Article
• Language: English
• Subjects: 16S rRNA; Clinical isolates; Cocci; Desorption; Gene sequencing; Gram-negative bacteria; Gram-positive cocci; Identification; Identification methods; Ionization; Ions; MALDI-TOF; Mass spectrometry; Mass spectroscopy; Microorganisms; New technology; Nocardia; rRNA 16S; Scientific imaging; Species; Spectroscopy; Strains (organisms)
• ISSN: 0342-3026; 2567-9430; 1439-0477; 2567-9449
• DOI: 10.1515/labmed-2018-0180

The routine identification to the species level of Nocardia genus by conventional methods is a fastidious and time-consuming process owing to the limited biochemical reactivity of these microorganisms, often requiring 1 or more days to complete identification. Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) is a new technology for definitive and rapid species identification.We evaluated the MALDI-TOF MS for the identification of 44 clinical isolates of Nocardia species in comparison to 16S ribosomal RNA (rRNA) gene sequencing. Nocardia isolates were identified by microbiological examination, phenotypical tests and MALDI-TOF MS and the results were compared by 16S rRNA gene sequencing.Of the 44 Nocardia strains, the identification of 28 isolates was determined with MALDI Biotyper database. According to this, 16 isolates (57.1%) of the strain log scores were ≥2. Two (7.1%) were identified to the species level (log scores of ≥2) as Nocardia otitidiscaviarum. The addition of a newly established Nocardia database (16 new Nocardia strains included to the original database) did significantly improve the scores. The results were 43 (97.7%) correct identification to the species level (log scores of ≥2).This study showed that the identification of clinical Nocardia isolates by the Bruker MALDI Biotyper is highly reliable, whereas identification rates are generally lower than those for some Gram-negative bacteria and Gram-positive cocci. Based on our data, the identification rates can be improved by validated new database entries and the results can be confirmed with nucleic acid sequence analysis.